Sunshine Biopharma Inc. 8-K Summary
Business Context and Reporting Period
Sunshine Biopharma Inc. (SBFM), a Colorado corporation, filed this Current Report on Form 8-K on August 7, 2024. The company is incorporated in Colorado and maintains its principal executive offices in Fort Lauderdale, Florida. Its common stock and warrants trade on The Nasdaq Stock Market LLC under the symbols SBFM and SBFMW, respectively.
Key Financial Metrics
This filing is a current report regarding a corporate action and does not contain financial statements. Consequently, the filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
The primary material event reported is a 1-for-20 reverse stock split of the Company's common stock. The Company filed a certificate of amendment to its articles of incorporation with the Secretary of State of Colorado effective August 7, 2024. The market effective date for this reverse split was August 8, 2024.
Guidance, Outlook, and Risks
The filing does not include management commentary, financial guidance, outlook, or specific risk factors beyond the standard disclosure of the reverse split. No unusual items or contingencies were disclosed in this report.
Investor Verification Checklist
- Verify the post-split share count and adjusted share price on August 8, 2024.
- Confirm the treatment of outstanding Common Stock Purchase Warrants (SBFMW) following the 1-for-20 reverse split.
- Review the filed Certificate of Amendment (Exhibit 3.1) for specific details on the amendment to the Articles of Incorporation.
- Check subsequent filings for any impact on Nasdaq listing compliance requirements.